Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy-Reference-Cited by-同舟云学术

Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy

Published:2023-12 Issue:12 Volume:25 Page:1277-1284
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Burnham Andre J.^ORCID,Foppiani Elisabetta M.^ORCID,Goss Kyndal L.^ORCID,Jang-Milligan Fraser,Kamalakar Archana,Bradley Heath,Goudy Steven L.,Trochez Camila Medrano^ORCID,Dominici Massimo^ORCID,Daley-Bauer Lisa,Gibson Greg,Horwitz Edwin M.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference40 articles.

1. Human mesenchymal stem cellsࣧcurrent trends and future prospective;Ullah;Bioscience Reports,2015

2. Immunomodulatory properties of mesenchymal stromal cells;Nauta;Blood,2007

3. Multipotent mesenchymal stromal cells and the innate immune system;Le Blanc;Nature Reviews Immunology,2012

4. Isolated allogeneic bone marrow–derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone;Horwitz;Proc Natl Acad Sci U S A,,2002

5. Stem cell therapy in coronavirus disease 2019: current evidence and future potential;Shetty;Cytotherapy,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proinflammatory cytokines sensitise mesenchymal stromal cells to apoptosis;2024-08-22

2. Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells;Stem Cells;2024-06-03